SCHEMBL6286653

SCHEMBL6286653

CC(O)Oc1ccc(C(=O)OCc2ccccc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.63
TDP1 Q9NUW8 4/20 0.63
SLC6A2 P23975 1/20 0.63
SLC6A3 Q01959 1/20 0.63
LMNA P02545 4/20 0.62
MAPT P10636 5/20 0.58
ALDH1A1 P00352 5/20 0.58
HPGD P15428 1/20 0.58
RAB9A P51151 3/20 0.53
GAA P10253 1/20 0.53
NPC1 O15118 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
ADRB2 P07550 1/20 0.51
ADRB1 P08588 1/20 0.51
ADRB3 P13945 1/20 0.51
L3MBTL1 Q9Y468 3/20 0.50
MEN1 O00255 1/20 0.50
MAOB P27338 1/20 0.48
PARP10 Q53GL7 1/20 0.48
CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7401587 0.90 KMT2A (0.65) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL6285409 0.86 KMT2A (0.59) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL10148420 0.86 KMT2A (0.59) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL10148422 0.86 KMT2A (0.59) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL12393817 0.85 KMT2A (0.63) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL13845264 0.83 KMT2A (0.56) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL12391751 0.83 LMNA (0.74) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL312287 0.82 KMT2A (0.92) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL9329147 0.82 KMT2A (0.67) KMT2ATDP1SLC6A2SLC6A3LMNA
SCHEMBL2704247 0.81 KMT2A (0.71) KMT2ATDP1SLC6A2SLC6A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6846900-B2 POLYVALENT CARBOXYLIC ACID ESTER, PROCESS FOR PRODUCING THE CARBOXYLIC ACID ESTER, PLASTIC LENS COMPOSITION USING THE CARBOXYLIC ESTER, PLASTIC LENS OBTAINED BY CURING THE COMPOSITION AND PROCESS FOR PRODUCING THE PLASTIC LENS SHOWA DENKO K.K. (JP) 2005-01-25 US disclosed
US-20030144447-A1 Novel polyvalent carboxylic acid ester and their use in plastic lens compositions SHOW A DENKO K.K. (JP) 2003-07-31 US disclosed
WO-2002079140-A1 NOVEL POLYVALENT CARBOXYLIC ACID ESTERS AND THEIR USE IN PLASTIC LENS COMPOSITIONS SHOWA DENKO K. K. (JP) 2002-10-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144447-A1 Novel polyvalent carboxylic acid ester and their use in plastic lens compositions VCL, VIM, CRYAA KMT2A 334/4885TDP1 3601/4885SLC6A2 4864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.